How Early in Pregnancy Can You Do a DNA Test?

Discover how early in pregnancy you can do a DNA test with NIPT. US-based guide to non-invasive prenatal testing timing, accuracy, and what to expect. Learn more.

You can do a DNA test as early as 9 to 10 weeks into pregnancy using Non-Invasive Prenatal Testing (NIPT), which analyzes cell-free fetal DNA circulating in your blood. This simple blood draw screens for common chromosomal conditions without risk to the pregnancy. In the United States, NIPT is the earliest reliable DNA-based screening available, offering results that help you and your healthcare team make informed decisions about further testing or care.

What Is Non-Invasive Prenatal Testing (NIPT)?

NIPT, also called non-invasive prenatal screening or cell-free DNA testing, looks at small fragments of fetal DNA that naturally cross the placenta into your bloodstream. It is a screening tool, not a diagnostic test, meaning it identifies pregnancies with a higher chance of certain chromosomal abnormalities. The test is typically performed after 9 weeks of gestation when enough fetal DNA (the fetal fraction) is present for accurate analysis. NIPT is recommended by the American College of Obstetricians and Gynecologists (ACOG) for all pregnancies, regardless of maternal age or risk profile.

How Early Can You Take an NIPT DNA Test?

Most US laboratories offer NIPT starting at 9 weeks of pregnancy, though some may require you to be at least 10 weeks. The key factor is the fetal fraction—the percentage of cell-free DNA from the placenta. At 9 weeks, the fetal fraction is usually around 4–5%, which is sufficient for reliable screening. If your fetal fraction is too low, the lab may ask you to repeat the draw a week or two later. This early window aligns with the first-trimester screening period, making NIPT a convenient option when combined with an early ultrasound.

What Conditions Does NIPT Screen For?

NIPT primarily screens for common trisomies: Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome). It can also evaluate sex chromosome aneuploidies (like Turner syndrome) and, in expanded panels, small microdeletions such as DiGeorge syndrome. Note that NIPT does not screen for open neural tube defects or most single-gene disorders—those require separate tests like the quad screen or carrier screening. Many US providers offer a combined first-trimester screening that pairs NIPT with a nuchal translucency ultrasound to provide even earlier risk assessment.

How Accurate Is Early NIPT?

When performed at 9–10 weeks, NIPT has detection rates greater than 99% for Trisomy 21 and over 97% for Trisomies 18 and 13, with very low false-positive rates (under 0.5%). However, because it is a screening test, a positive result must be confirmed with diagnostic testing such as chorionic villus sampling (CVS) or amniocentesis. Factors like a vanishing twin, mosaicism, or a low fetal fraction (sometimes due to high maternal BMI) can affect accuracy. Discussing your results with a genetic counselor is a standard part of the follow-up process.

When Should You Consider Other DNA Tests?

NIPT is the earliest non-invasive DNA test, but other genetic tests are available depending on your needs. If NIPT reveals a high chance of a condition, your provider may offer CVS (performed at 10–13 weeks) or amniocentesis (15–20 weeks) for a definitive diagnosis. If you are interested in paternity before birth, a prenatal paternity test using cell-free fetal DNA can be done as early as 9 weeks and is also non-invasive. Additionally, carrier screening for inherited conditions like cystic fibrosis, spinal muscular atrophy (SMA), and fragile X syndrome can be performed before or during pregnancy and often involves a separate blood sample.

Comparison of Prenatal DNA Test Timelines

Note: Only NIPT and prenatal paternity tests are non-invasive and available in the first trimester. Invasive tests carry a small risk of miscarriage and are reserved for diagnostic confirmation.

Factors That Influence Early DNA Test Timing

• Fetal fraction: The amount of fetal cfDNA must typically reach at least 3–4% for accurate results. This threshold is normally met by 9–10 weeks but can be delayed.
• Maternal weight: Higher BMI can dilute the fetal fraction, sometimes requiring a later blood draw (e.g., 11–12 weeks) to achieve adequate levels.
• Multiple pregnancies: In twins or higher-order multiples, the fetal fraction per baby is lower, so some labs recommend waiting until 10–11 weeks.
• Laboratory policy: Some US labs set a minimum of 10 weeks for standard NIPT panels; verify with the specific lab your provider uses.
• Combined screening protocols: Many practices pair NIPT with a nuchal translucency ultrasound (ideally at 11–13 weeks) for a comprehensive first-trimester risk assessment.

Making an Informed Decision

Understanding how early a DNA test is possible allows you to plan your prenatal care timeline. NIPT at 9–10 weeks gives you results early enough to consider further testing or prepare for a child with special needs. Always review your options with your obstetrician or a genetic counselor, especially if you have a family history of genetic conditions. For a complete picture, many US patients choose a broad prenatal screening panel that includes NIPT plus carrier screening for hundreds of recessive disorders.

If you are ready to take the next step, you can order a comprehensive prenatal screening panel online and get results quickly. Order a prenatal screening panel online to gain early, actionable insights into your pregnancy.